Apolipoprotein E has been shown to be a risk factor for late-onset Alzheimer's disease, with the apolipoprotein e4 allele conferring the risk. Apolipoprotein E is found in neurofibrillary tangles and senile plaques, the pathological characteristics of Alzheimer's disease. To date there is no direct evidence that human neurons can take up exogenous apolipoprotein E, which is necessary if apolipoprotein E is involved in the formation of neurofibrillary tangles. To examine apolipoprotein E uptake we employed the human NTera2/D1 cell line, which can be induced by retinoic acid to differentiate into postmitotic NTera2-N neurons, which have the characteristics and morphology of human central nervous system neurons. We defined the cell line as genotype apolipoprotein e3/3 and demonstrated that the cells do not synthesize apolipoprotein E but can take up and internalize exogenous recombinant apolipoprotein E3. We also confirmed the expression of the low-density lipoprotein receptor-related protein, a known receptor for apolipoprotein E. The NTera2/D1 cell line therefore provides a useful human cell model for examining the effects of other apolipoprotein E isoforms with a view to defining intraneuronal interactions of apolipoprotein E. r 1997 Academic Press
INTRODUCTION
Serum apolipoprotein E (apoE protein, APOE gene) is a 34-kDa glycoprotein component of very lowdensity lipoproteins and high-density lipoproteins. ApoE mediates the cellular uptake of lipoprotein by binding to the low-density lipoprotein receptor (LDLR) and the low-density lipoprotein receptor-related protein (LRP) (Mahley and Innerarity, 1983; Mahley, 1988) . A larger disialated 35-kDa form of apoE is the primary apolipoprotein in cerebrospinal fluid (Roheim et al., 1979; Pitas et al., 1987a) and may be important in the growth, maintenance, and repair of neuronal membranes and myelin formation in the nervous system (Muller et al., 1985; Ignatius et al., 1986; Snipes et al., 1986; Boyles et al., 1990) .
Recent findings show that the risk of late-onset Alzheimer's disease is significantly associated with the inheritance of an APOE allele, e4 (Anwar et al., 1993; Poirier et al., 1993; Strittmatter et al., 1993a; Houlden et al., 1994; Tsai et al., 1994) . The APOE gene is located on chromosome 19 with three major alleles, e3, e4, and e2, in frequencies of approximately 77, 15, and 8%, respectively (Utermann et al., 1980; Breslow, 1985) , yet the e4 frequency is increased to 40% in people with late-onset Alzheimer's disease (Saunders et al., 1993; Strittmatter et al., 1993a) . Risk of late-onset Alzheimer's disease increases from 20 to 90% and the mean age of onset decreases from 84 to 68 years, with increasing number of e4 alleles in the genotype (Corder et al., 1993) . Conversely, the e2 allele lowers the risk and increases the age of onset (Corder et al., 1994) . In Alzheimer's disease, apoE immunostaining is localized to the intraneuronal neurofibrillary tangles
